Citadel Advisors
NUTX

Citadel Advisors’s Nutex Health NUTX Stock Holding History

Citadel Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,737
Closed -$839K – 13688
2025
Q2 		$839K Buy
+6,737
New +$870K ﹤0.01% 7475
2022
Q3 		– Sell
-1,735
Closed -$839K – 13286
2022
Q2 		$839K Buy
+1,735
New +$2.05M ﹤0.01% 7441

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's NUTX Position: Q3 2025 in Review

Citadel Advisors sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 6,737 shares — an estimated $839K sold.

Citadel Advisors first reported a position in NUTX in Q2 2022 and held it in 2 quarters. The position peaked at $839K in Q2 2022. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • Citadel Advisors reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 6,737 Nutex Health shares in Q3 2025, an estimated $839K.
  • Citadel Advisors first reported a position in Nutex Health in Q2 2022 and held it in 2 quarters.
  • Citadel Advisors's Nutex Health position peaked at $839K in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.